168 related articles for article (PubMed ID: 24503291)
1. Novel surfactant for preparation of poly(L-lactic acid) nanoparticles with controllable release profile and cytocompatibility for drug delivery.
Li F; Zhu A; Song X; Ji L
Colloids Surf B Biointerfaces; 2014 Mar; 115():377-83. PubMed ID: 24503291
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.
Songsurang K; Suvannasara P; Phurat C; Puthong S; Siraleartmukul K; Muangsin N
Carbohydr Polym; 2013 Nov; 98(2):1335-42. PubMed ID: 24053811
[TBL] [Abstract][Full Text] [Related]
3. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
4. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
[TBL] [Abstract][Full Text] [Related]
7. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
Essa S; Louhichi F; Raymond M; Hildgen P
J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
9. Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles.
Amini MA; Faramarzi MA; Gilani K; Moazeni E; Esmaeilzadeh-Gharehdaghi E; Amani A
J Microencapsul; 2014; 31(5):422-9. PubMed ID: 24697188
[TBL] [Abstract][Full Text] [Related]
10. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
Xing J; Zhang D; Tan T
Int J Biol Macromol; 2007 Jan; 40(2):153-8. PubMed ID: 16901536
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and drug release property of paclitaxel nanoparticles].
Wang TW; Wu Y; Li MJ; Gao HX
Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
[TBL] [Abstract][Full Text] [Related]
12. Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery.
Xiong XY; Li QH; Li YP; Guo L; Li ZL; Gong YC
Colloids Surf B Biointerfaces; 2013 Nov; 111():282-8. PubMed ID: 23838194
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
14. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
15. Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior.
Karavelidis V; Giliopoulos D; Karavas E; Bikiaris D
Eur J Pharm Sci; 2010 Dec; 41(5):636-43. PubMed ID: 20863892
[TBL] [Abstract][Full Text] [Related]
16. Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile.
Ishihara T; Izumo N; Higaki M; Shimada E; Hagi T; Mine L; Ogawa Y; Mizushima Y
J Control Release; 2005 Jun; 105(1-2):68-76. PubMed ID: 15955367
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and in vitro evaluation of brucine-loaded polylacticacid nanoparticles].
Zhao J; Liu Z; Xu J; Yu Y; Feng N
Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2322-4. PubMed ID: 20030079
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactic acid)/N-maleoylchitosan core-shell capsules: preparation and drug release properties.
Zhu A; Li F; Ji L
Colloids Surf B Biointerfaces; 2012 Mar; 91():162-7. PubMed ID: 22100385
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of alkyl polyglucoside as an alternative surfactant in the preparation of peptide-loaded nanoparticles.
Patel AR; Kulkarni S; Nandekar TD; Vavia PR
J Microencapsul; 2008 Dec; 25(8):531-40. PubMed ID: 18465296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
